Researchers analysed the data of 222,007 UK Biobank participants — women aged 40-69 years without prior cardiovascular disease who reported their menopausal status — to evaluate the association between menopause and the 10-year risk for ASCVD. Of these participants, 158,572 (71.4%) were postmenopausal and 63,435 (28.6%) were premenopausal.
The estimated 10-year risk for ASCVD (expressed in percentage) was assessed using a pooled cohort equation score, with a score ≥ 7.5% being classified as high risk and < 7.5% being classified as low risk.
The authorsconcludedthat the usualassessment of cardiovasculardiseaseriskshouldincludemenopausalstatus,andpreventivestrategiesshouldbetailoredtothispopulationgroup, with particularattention to lipidcontrol, bloodpressure control,glucoseregulation, andlifestylechanges.
https://www.medscape.com/viewarticle/menopause-linked-higher-ascvd-risk-2025a1000m92
The estimated 10-year risk for ASCVD (expressed in percentage) was assessed using a pooled cohort equation score, with a score ≥ 7.5% being classified as high risk and < 7.5% being classified as low risk.